Vanberra Signal

Medix Biotechnologies

Curated by Signal

Provider of hypersensitive pathogen detection kits and platform for the IVD industry

Overview

Provider of hypersensitive pathogen detection kits and platform for the IVD industry. It offers Hypersens a pathogen detection kits offer a comprehensive detection of multiple pathogens and antibiotic resistance genes from a single sample. It also provide AI-driven assay for detecting pathogens, antibiotic resistant genes and other genomic material. and software tool that maps out targeted antibiotic treatment options.

Key facts

Founded
2023

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Digital electromyography data reporting tool for providers

    Life Sciences TechnologyPhoenix, United States
  • A wearable solution to monitor and manage asthma condition

    Life Sciences TechnologyWest Henrietta, United States
  • Provider tools to help researchers with protein analysis

    Life Sciences TechnologySan Jose, United States

About Medix Biotechnologies

What does Medix Biotechnologies do?

Provider of hypersensitive pathogen detection kits and platform for the IVD industry.

Where is Medix Biotechnologies headquartered?

Medix Biotechnologies is headquartered in Santa Clara, United States.

When was Medix Biotechnologies founded?

Medix Biotechnologies was founded in 2023.

Which sector is Medix Biotechnologies in?

Medix Biotechnologies operates in Life Sciences Technology.

Who are Medix Biotechnologies's competitors?

Companies similar to Medix Biotechnologies include Noraxon, Health Care Originals, and ProteinSimple.